Cancer Letters
Volume 290, Issue 2 , Pages 223-237 , 28 April 2010

PI 3-kinase/Akt and STAT3 are required for the prevention of TGF-β-induced Hep3B cell apoptosis by autocrine motility factor/phosphoglucose isomerase

  • Wen-Ling Shih

      Affiliations

    • Graduate Institute of Biotechnology, National Pingtung University of Science and Technology, Pingtung, Taiwan
    • Corresponding Author InformationCorresponding author. Address: Graduate Institute of Biotechnology, National Pingtung University of Science and Technology, 1, Shuefu Rd., Neipu, Pingtung 91201, Taiwan. Tel.: +886 8 7703202x5192; fax: +886 8 7740550.
    • ,
  • Ming-Huei Liao

      Affiliations

    • Department of Veterinary Medicine, National Pingtung University of Science and Technology, Pingtung, Taiwan
    • ,
  • Ping-Yuan Lin

      Affiliations

    • Graduate Institute of Life Science, Tzu-Chi University, Hualien, Taiwan
    • ,
  • Chi-I Chang

      Affiliations

    • Graduate Institute of Biotechnology, National Pingtung University of Science and Technology, Pingtung, Taiwan
    • ,
  • Hsueh-Ling Cheng

      Affiliations

    • Graduate Institute of Biotechnology, National Pingtung University of Science and Technology, Pingtung, Taiwan
    • ,
  • Feng-Ling Yu

      Affiliations

    • Department of Nursing, Tzu-Hui Institute of Technology, Pingtung, Taiwan
    • ,
  • Jeng-Woei Lee

      Affiliations

    • Graduate Institute of Life Science, Tzu-Chi University, Hualien, Taiwan

Received 22 May 2009 ,Revised 16 September 2009 ,Accepted 17 September 2009.

References 

  1. Michalopoulos GK, DeFrances MC. Liver regeneration. Science. 1997;276:60–66
  2. Lin JK, Chou CK. In vitro apoptosis in the human hepatoma cell line induced by transforming growth factor beta 1. Cancer Res. 1992;52:385–388
  3. Fukuda K, Kojiro M, Chiu JF. Differential regulation of tissue transglutaminase in rat hepatoma cell lines McA-RH7777 and McA-RH8994: relation to growth rate and cell death. J. Cell. Biochem. 1994;54:67–77
  4. Fan G, Ma X, Kren BT, Steer CJ. The retinoblastoma gene product inhibits TGF-beta1 induced apoptosis in primary rat hepatocytes and human HuH-7 hepatoma cells. Oncogene. 1996;12:1909–1919
  5. Derynck R, Feng XH. TGF-beta receptor signaling. Biochim. Biophys. Acta. 1997;1333:F105–F150
  6. Piek E, Franzen P, Heldin CH, ten Dijke P. Characterization of a 60-kDa cell surface-associated transforming growth factor-beta binding protein that can interfere with transforming growth factor-beta receptor binding. J. Cell. Physiol. 1997;173:447–459
  7. Zhang Y, Derynck R. Regulation of Smad signalling by protein associations and signalling crosstalk. Trends Cell Biol. 1999;9:274–279
  8. Chen RH, Chang TY. Involvement of caspase family proteases in transforming growth factor-beta-induced apoptosis. Cell Growth Differ. 1997;8:821–827
  9. Jang CW, Chen CH, Chen CC, Chen JY, Su YH, Chen RH. TGF-beta induces apoptosis through Smad-mediated expression of DAP-kinase. Nat. Cell. Biol. 2002;4:51–58
  10. Tanaka S, Wands JR. Insulin receptor substrate 1 overexpression in human hepatocellular carcinoma cells prevents transforming growth factor beta1-induced apoptosis. Cancer Res. 1996;56:3391–3394
  11. Chen RH, Chang MC, Su YH, Tsai YT, Kuo ML. Interleukin-6 inhibits transforming growth factor-beta-induced apoptosis through the phosphatidylinositol 3-kinase/Akt and signal transducers and activators of transcription 3 pathways. J. Biol. Chem. 1999;274:23013–23019
  12. Zha J, Harada H, Yang E, Jockel J, Korsmeyer SJ. Serine phosphorylation of death agonist BAD in response to survival factor results in binding to 14-3-3 not BCL-X(L). Cell. 1996;87:619–628
  13. Cardone MH, Roy N, Stennicke HR, Salvesen GS, Franke TF, Stanbridge E, et al. Regulation of cell death protease caspase-9 by phosphorylation. Science. 1998;282:1318–1321
  14. Kennedy SG, Kandel ES, Cross TK, Hay N. Akt/protein kinase B inhibits cell death by preventing the release of cytochrome c from mitochondria. Mol. Cell. Biol. 1999;19:5800–5810
  15. Shih WL, Kuo ML, Chuang SE, Cheng AL, Doong SL. Hepatitis B virus X protein inhibits transforming growth factor-beta-induced apoptosis through the activation of phosphatidylinositol 3-kinase pathway. J. Biol. Chem. 2000;275:25858–25864
  16. Rose IA, O’Connell EL. Intramolecular hydrogen transfer in the phosphoglucose isomerase reaction. J. Biol. Chem. 1961;236:3086–3092
  17. Schray KJ, Benkovic SJ, Benkovic PA, Rose IA. Catalytic reactions of phosphoglucose isomerase with cyclic forms of glucose 6-phosphate and fructose 6-phosphate. J. Biol. Chem. 1973;248:2219–2224
  18. Welch SG. Qualitative and quantitative variants of human phosphoglucose isomerase. Hum. Hered. 1971;21:467–477
  19. Beutler E, West C, Britton HA, Harris J, Forman L. Glucosephosphate isomerase (GPI) deficiency mutations associated with hereditary nonspherocytic hemolytic anemia (HNSHA). Blood Cells Mol. Dis. 1997;23:402–409
  20. Huppke P, Wunsch D, Pekrun A, Kind R, Winkler H, Schroter W, et al. Glucose phosphate isomerase deficiency: biochemical and molecular genetic studies on the enzyme variants of two patients with severe haemolytic anaemia. Eur. J. Pediatr. 1997;156:605–609
  21. Baumann M, Kappl A, Lang T, Brand K, Siegfried W, Paterok E. The diagnostic validity of the serum tumor marker phosphohexose isomerase (PHI) in patients with gastrointestinal, kidney, and breast cancer. Cancer Invest. 1990;8:351–356
  22. Watanabe H, Carmi P, Hogan V, Raz T, Silletti S, Nabi IR, et al. Purification of human tumor cell autocrine motility factor and molecular cloning of its receptor. J. Biol. Chem. 1991;266:13442–13448
  23. Torimura T, Ueno T, Kin M, Harada R, Nakamura T, Kawaguchi T, et al. Autocrine motility factor enhances hepatoma cell invasion across the basement membrane through activation of beta1 integrins. Hepatology. 2001;34:62–71
  24. Yu FL, Liao MH, Lee JW, Shih WL. Induction of hepatoma cells migration by phosphoglucose isomerase/autocrine motility factor through the upregulation of matrix metalloproteinase-3. Biochem. Biophys. Res. Commun. 2004;314:76–82
  25. Tsutsumi S, Hogan V, Nabi IR, Raz A. Overexpression of the autocrine motility factor/phosphoglucose isomerase induces transformation and survival of NIH-3T3 fibroblasts. Cancer Res. 2003;63:242–249
  26. Tsutsumi S, Yanagawa T, Shimura T, Fukumori T, Hogan V, Kuwano H, et al. Regulation of cell proliferation by autocrine motility factor/phosphoglucose isomerase signaling. J. Biol. Chem. 2003;278:32165–32172
  27. Haga A, Funasaka T, Niinaka Y, Raz A, Nagase H. Autocrine motility factor signaling induces tumor apoptotic resistance by regulations Apaf-1 and Caspase-9 apoptosome expression. Int. J. Cancer. 2003;107:707–714
  28. Shih WL, Liao MH, Yu FL, Lin PY, Hsu HY, Chiu SJ. AMF/PGI transactivates the MMP-3 gene through the activation of Src-RhoA-phosphatidylinositol 3-kinase signaling to induce hepatoma cell migration. Cancer Lett. 2008;270:202–217
  29. Feng XH, Filvaroff EH, Derynck R. Transforming growth factor-beta (TGF-beta)-induced down-regulation of cyclin A expression requires a functional TGF-beta receptor complex. Characterization of chimeric and truncated type I and type II receptors. J. Biol. Chem. 1995;270:24237–24245
  30. Hu Q, Klippel A, Muslin AJ, Fantl WJ, Williams LT. Ras-dependent induction of cellular responses by constitutively active phosphatidylinositol-3 kinase. Science. 1995;268:100–102
  31. Kulik G, Klippel A, Weber MJ. Antiapoptotic signalling by the insulin-like growth factor I receptor, phosphatidylinositol 3-kinase, and Akt. Mol. Cell. Biol. 1997;17:1595–1606
  32. Ning ZQ, Li J, McGuinness M, Arceci RJ. STAT3 activation is required for Asp(816) mutant c-Kit induced tumorigenicity. Oncogene. 2001;20:4528–4536
  33. Lin PY, Liu HJ, Liao MJ, Yu FL, Hsu HY, Lee JW, et al. Avian reovirus activates a novel proapoptotic signal by linking Src to p53. Apoptosis. 2006;11:2179–2193
  34. Yeh CJ, Lin PY, Liao MH, Liu HJ, Lee JW, Chiu SJ, et al. TNF-alpha mediates pseudorabies virus-induced apoptosis via the activation of p38 MAPK and JNK/SAPK signaling. Virology. 2008;38:55–66
  35. Lin PY, Lee JW, Liao MH, Hsu HY, Chiu SJ, Liu HJ, et al. Modulation of p53 by mitogen-activated protein kinase pathways and protein kinase C delta during avian reovirus S1133-induced apoptosis. Virology. 2009;385:323–334
  36. Chou CC, Sun YJ, Meng M, Hsiao CD. The crystal structure of phosphoglucose isomerase/autocrine motility factor/neuroleukin complexed with its carbohydrate phosphate inhibitors suggests its substrate/receptor recognition. J. Biol. Chem. 2000;275:23154–23160
  37. Lin HY, Kao YH, Chen ST, Meng M. Effects of inherited mutations on catalytic activity and structural stability of human glucose-6-phosphate isomerase expressed in Escherichia coli. Biochim. Biophys. Acta. 2009;1794:15–323
  38. Havasi A, Li Z, Wang Z, Martin JL, Botla V, Ruchalski K, et al. Hsp27 inhibits Bax activation and apoptosis via a phosphatidylinositol 3-kinase-dependent mechanism. J. Biol. Chem. 2008;283:12305–12313
  39. Inoue T, Suzuki Y, Yoshimaru T, Ra C. Nitric oxide protects mast cells from activation-induced cell death: the role of the phosphatidylinositol-3 kinase-Akt-endothelial nitric oxide synthase pathway. J. Leukoc. Biol. 2008;83:1218–1229
  40. Ruano Y, Mollejo M, Camacho FI, Rodriguez de Lope A, Fiano C, Ribalta T, et al. Identification of survival-related genes of the phosphatidylinositol 3′-kinase signaling pathway in glioblastoma multiforme. Cancer. 2008;112:1575–1584
  41. Vasconsuelo A, Milanesi L, Boland R. 17 Beta-estradiol abrogates apoptosis in murine skeletal muscle cells through estrogen receptors: role of the phosphatidylinositol 3-kinase/Akt pathway. J. Endocrinol. 2008;196:385–397
  42. Hashimoto O, Ueno T, Kimura R, Ohtsubo M, Nakamura T, Koga H, et al. Inhibition of proteasome-dependent degradation of Wee1 in G2-arrested Hep3B cells by TGF beta 1. Mol. Carcinog. 2003;36:171–182
  43. Vadrot N, Legrand A, Nello E, Bringuier AF, Guillot R, Feldmann G. Inducible nitric oxide synthase (iNOS) activity could be responsible for resistance or sensitivity to IFN-gamma-induced apoptosis in several human hepatoma cell lines. J. Interferon. Cytokine Res. 2006;26:901–913
  44. Heldin CH, Landstrom M, Moustakas A. Mechanism of TGF-beta signaling to growth arrest, apoptosis, and epithelial-mesenchymal transition. Curr. Opin. Cell. Biol. 2009;21:166–176
  45. Dennler S, Itoh S, Vivien D, ten Dijke P, Huet S, Gauthier JM. Direct binding of Smad3 and Smad4 to critical TGF beta-inducible elements in the promoter of human plasminogen activator inhibitor-type 1 gene. EMBO J. 1998;17:3091–3100
  46. Hua X, Miller ZA, Wu G, Shi Y, Lodish HF. Specificity in transforming growth factor beta-induced transcription of the plasminogen activator inhibitor-1 gene: interactions of promoter DNA, transcription factor muE3, and Smad proteins. Proc. Natl. Acad. Sci. USA. 1999;96:13130–13135
  47. Mebratu Y, Tesfaigzi Y. How ERK1/2 activation controls cell proliferation and cell death is subcellular localization the answer?. Cell Cycle. 2009;8:1–8
  48. Ahmed NN, Grimes HL, Bellacosa A, Chan TO, Tsichlis PN. Transduction of interleukin-2 antiapoptotic and proliferative signals via Akt protein kinase. Proc. Natl. Acad. Sci. USA. 1997;94:3627–3632
  49. Dudek H, Datta SR, Franke TF, Birnbaum MJ, Yao R, Cooper GM, et al. Regulation of neuronal survival by the serine–threonine protein kinase Akt. Science. 1997;275:661–665
  50. Ammar H, Closset JL. Clusterin activates survival through the phosphatidylinositol 3-kinase/Akt pathway. J. Biol. Chem. 2008;283:12851–12861
  51. Belkhiri A, Dar AA, Zaika A, Kelley M, El-Rifai W. t-Darpp promotes cancer cell survival by up-regulation of Bcl2 through Akt-dependent mechanism. Cancer Res. 2008;68:395–403
  52. Hu JP, Nishishita K, Sakai E, Yoshida H, Kato Y, Tsukuba T, et al. Berberine inhibits RANKL-induced osteoclast formation and survival through suppressing the NF-kappaB and Akt pathways. Eur. J. Pharmacol. 2008;580:70–79
  53. Chen RH, Su YH, Chuang RL, Chang TY. Suppression of transforming growth factor-beta-induced apoptosis through a phosphatidylinositol 3-kinase/Akt-dependent pathway. Oncogene. 1998;17:1959–1968
  54. Kohn AD, Kovacina KS, Roth RA. Insulin stimulates the kinase activity of RAC-PK, a pleckstrin homology domain containing ser/thr kinase. EMBO J. 1995;14:4288–4295
  55. Datta SR, Dudek H, Tao X, Masters S, Fu H, Gotoh Y, et al. Akt phosphorylation of BAD couples survival signals to the cell-intrinsic death machinery. Cell. 1997;91:231–241
  56. Chung J, Kuo CJ, Crabtree GR, Blenis J. Rapamycin-FKBP specifically blocks growth-dependent activation of and signaling by the 70 kd S6 protein kinases. Cell. 1992;69:1227–1236
  57. Lee SO, Lou W, Johnson CS, Trump DL, Gao AC. Interleukin-6 protects LNCaP cells from apoptosis induced by androgen deprivation through the STAT3 pathway. Prostate. 2004;60:178–186
  58. Sekikawa A, Fukui H, Fujii S, Ichikawa K, Tomita S, Imura J, et al. REG Ialpha protein mediates an anti-apoptotic effect of STAT3 signaling in gastric cancer cells. Carcinogenesis. 2008;29:76–83
  59. Darnell JE, Kerr IM, Stark GR. Jak-STAT pathways and transcriptional activation in response to IFNs and other extracellular signaling proteins. Science. 1994;264:1415–1421
  60. Ihle JN, Kerr IM. Jaks and stats in signaling by the cytokine receptor superfamily. Trends Genet. 1995;11:69–74

PII: S0304-3835(09)00602-8

doi: 10.1016/j.canlet.2009.09.014

Cancer Letters
Volume 290, Issue 2 , Pages 223-237 , 28 April 2010

Article Tools

* Image Usage & Resolution